Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted.
about
Inhibition of RNA Recruitment and Replication of an RNA Virus by Acridine Derivatives with Known Anti-Prion ActivitiesThe Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesHuman SCARB2-mediated entry and endocytosis of EV71Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.Entry of tiger frog virus (an Iridovirus) into HepG2 cells via a pH-dependent, atypical, caveola-mediated endocytosis pathwayCoronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Angiotensin-converting enzyme 2: the first decade.Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competenceHeptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathwayModulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entryMouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15RNA interference and antiviral therapy.SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro.From endocytosis to membrane fusion: emerging roles of dynamin in virus entry.IFITMs restrict the replication of multiple pathogenic virusesSevere acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpainClathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activationSARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry.Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.Transdifferentiation of MALME-3M and MCF-7 Cells toward Adipocyte-like Cells is Dependent on Clathrin-mediated Endocytosis.An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.Early events during human coronavirus OC43 entry to the cell.Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells.
P2860
Q27489873-3BC2C24D-5864-4B96-A273-1C72B6CD7BCFQ28271798-DFCC464C-32B9-430D-9C3B-4F77B270E2D2Q28478931-4A35A45F-0CB3-45C2-B921-5549D0698F3EQ30419612-BD2E7557-67C7-44E5-9638-EBD11DED9A4AQ30432156-F4283C41-0305-4C1F-AEC6-1AE2F645D995Q34015988-E06A3192-2C7B-4D5E-A1DC-FB88500B4B72Q34058365-8A37F1F0-C178-4466-BAB3-DE6E54CD33BCQ34510691-0D975ADF-F11F-46F5-AFFD-4470A76BE29EQ35077445-57EB092D-5BD2-4941-AF32-86C906D2DA9FQ35399141-E442DB0C-D12D-4E13-B321-1A554FE0F875Q35550937-1235F3C6-C9D6-45F1-B1C2-51DA5D7F625EQ35943657-3F7CA765-00D7-470A-B07D-B4D07F2534E1Q36424025-356E6FED-10C0-412F-B19E-CC7E2D7571E6Q36693984-E8B60034-B5C8-4786-9821-43E28634DF8AQ36845684-2E27F264-3198-4309-B4A9-B52E05B83015Q36944914-7A502B88-0621-40E5-8F1D-238FFBA92B67Q37234254-562041D5-2CC1-4176-BFF8-0EB1206F4A23Q38022050-E2BF80D1-F488-4DA3-828D-5732CCF036D8Q38146443-4F9001B7-32C6-4D28-8CE1-45CDD90648FDQ39316066-7678D03B-00A1-46F1-91DF-E7743EF8825EQ39870668-BDB070E0-790C-42DD-A51D-77A19D33778FQ40019559-8CF0D24C-443E-402E-B9E9-54B380BA0942Q42786664-7D68AA67-356A-43C9-9925-69EAA9FCB7A7Q42811827-4A462B34-5B28-4C43-9972-150B5B8D2290Q43070425-E4B04698-E827-4C85-A649-2ECBABE66F6EQ43238555-2D71A887-0A10-431C-BA4F-9655B3AE6C2DQ47765982-041F4FA5-FBE4-42C9-9645-426DD9F03AFDQ54217711-91163EF5-3BEA-4050-8B7C-3E784A854B5BQ55517889-D78CBC28-417B-4A19-B423-48055276ECC4
P2860
Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clathrin-dependent entry of se ...... the cytoplasmic tail deleted.
@en
type
label
Clathrin-dependent entry of se ...... the cytoplasmic tail deleted.
@en
prefLabel
Clathrin-dependent entry of se ...... the cytoplasmic tail deleted.
@en
P2093
P2860
P356
P1433
P1476
Clathrin-dependent entry of se ...... the cytoplasmic tail deleted.
@en
P2093
Kazuo Sugamura
Kouichi Morita
Min Zhuang
Nobuyuki Tanaka
Shingo Inoue
Toshio Hattori
Yoshinori Tanaka
Yuuki Inoue
P2860
P304
P356
10.1128/JVI.00253-07
P407
P577
2007-05-23T00:00:00Z